Impaired Akt phosphorylation in insulin-resistant human muscle is accompanied by selective and heterogeneous downstream defects
Katherine Tonks(Garvan Institute of Medical Research), Jerry R. Greenfield(Garvan Institute of Medical Research), Yi Zhen Ng(Agency for Science, Technology and Research), David E. James(The University of Sydney), Jagath R. Junutula(Chrono Therapeutics (United States)), Donald J. Chisholm(Garvan Institute of Medical Research), Jean Yang(The University of Sydney), Aimin Xu(University of Hong Kong), Ellis Patrick(The University of Sydney), Adelle C.F. Coster(UNSW Sydney), Ganesh Kolumam(Laboratoire d’Imagerie Biomédicale), Dorit Samocha‐Bonet(Garvan Institute of Medical Research), Zora Modrušan(Unknown), Jacqueline Stöckli(The University of Sydney), Samantha Miller(The University of Texas at Austin), Tristan J. Iseli(The University of Sydney)
Cited by 125
Related Papers
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
|Nature Biotechnology|2008|1.4k
Regulated transport of the glucose transporter GLUT4
|Nature Reviews Molecular Cell Biology|2002|1.2k
Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States
|Diabetes|2006|1.1k
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
|Nature Biotechnology|2012|997